FrancophonIA/ELRC3.0 huggingface dataset:
English: General health perception Incontinence impact Symptom severity Role limitations Physical limitations Social limitations Personal relationships Emotions
Maltese: Impatt tal-inkontinenza Severità tas-sintomi Limitazzjonijiet tal-irwol
English: Kentera should be used with caution in elderly patients, who may be more sensitive to the effects of centrally acting anticholinergics and exhibit differences in pharmacokinetics.
Maltese: Kentera għandu jintuża b'kawtela f'pazjenti anzjani, li jistgħu jkunu aktar sensittivi għall-effetti ta' antikolinerġiċi li jaġixxu ċentralment u juru differenzi fil-farmakokinetika.
English: Apply a new Kentera patch twice weekly (every 3 to 4 days).
Maltese: Applika garża ta' Kentera ġdida darbtejn fil-ġimgħa (kull 3 sa 4 ijiem).
English: Common side effects: - redness or rash at the site of patch application - dry mouth - constipation - diarrhoea - upset stomach - stomach pain - headache or sleepiness - urinary tract infections - blurred vision - dizziness
Maltese: Effetti sekondarji mhux komuni - infezzjoni tal-bużżieqa tal-awrina - ansjetà - konfużjoni - nervi - aġitazzjoni - diffikultajiet biex torqod
English: It allows continued monitoring of the benefit/risk balance of the medicinal product.
Maltese: Rapport ta' Stima tar-Riskju Ambjentali
English: uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000).
Maltese: - Mhux komuni (taffettwa minn 1 sa 10 utenti minn kull 1,000) - Rari (taffettwa minn 1 sa 10 utenti minn kull 10,000)
English: The concomitant use of oxybutynin with other anticholinergic medicinal products or with other active substances that compete for CYP3A4 enzyme metabolism may increase the frequency or severity of dry mouth, constipation, and drowsiness.
Maltese: L-użu fl-istess ħin ta' oxybutynin ma' prodotti mediċinali antikolinerġiċi oħra jew ma' sustanzi attivi oħra li jikkompetu għall-metaboliżmu tal-enzima CYP3A4 jista' jżid il-frekwenza jew is-severità ta' ħalq xott, stitikezza, u ħedla.
English: Excipients: triacetin; acrylic adhesive (containing 2-ethylhexyl acrylate; N-vinyl pyrrolidone and hexamethyleneglycol dimethacrylate polymer domains).
Maltese: N-vinyl pyrrolidone u dominji tal-polimer hexamethyleneglycol dimethacrylate).Rinforz: kisja rqiqa ta' polyester/ethylene-vinyl acetate; kisja rqiqa ta' polyester silikonizzat.
English: Take special care with Kentera:
Maltese: Tużax Kentera:
English: During the double-blind treatment a significant positive effect on quality of life was seen with Kentera based on the Incontinence Impact Questionnaire (IIQ).
Maltese: Matul it-trattament double-blind intwera effett pożittiv sinifikanti fuq il-kwalità tal-ħajja b'Kentera bbażat fuq il-Kwestjonarju dwar l-Impatt tal-Inkontinenza (IIQ - Incontinence Impact Questionnaire).
English: Cartons of 30 sachets.
Maltese: Pakketti tal-kartun ta' 30 qartas.
English: Kentera led to consistent improvements in overactive bladder symptoms compared with placebo.
Maltese: Kentera wassal għal titjib konsistenti fis-sintomi ta' bużżieqa tal-awrina attiva ħafna meta mqabbel mal-plaċebo.
English: Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder
Maltese: Trattament sintomatiku ta' inkontinenza impulsiva u/jew żieda fil-frekwenza u l-urġenza urinarja kif tista' sseħħ f'pazjenti adulti bil-bużżieqa tal-awrina instabbli 4
English: If the patch comes off:
Maltese: Effett sekondarju komuni ħafna:
English: Ingestion of 100 mg oral oxybutynin chloride in association with alcohol has been reported in a 13 year old boy who experienced memory loss, and in a 34 year old woman who developed stupor, followed by disorientation and agitation on awakening, dilated pupils, dry skin, cardiac arrhythmia, and retention of urine.
Maltese: L-inġestjoni ta' 100 mg oxybutynin chloride mill-ħalq flimkien mal-alkoħol kienet irrappurtata f'tifel ta' 13-il sena li żviluppa telf tal memorja, u f'mara ta' 34 sena li żviluppat sturdament/nuqqas ta' koxjenza, segwit minn diżorjentament u aġitazzjoni mal-qawmien mill-irqad, twessigħ tal-pupilli, ġilda xotta, arritmija kardijaka, u żamma talawrina.
English: It is important you read and follow these directions on how to use the Kentera pump properly.
Maltese: L-ebda każ ta' doża eċċessiva ma kien irrappurtat b'Kentera.
English: As the stratum corneum is the rate-limiting step in transdermal delivery, any breach would provide direct access to the epidermis, potentially increasing penetration and facilitating the migration of the medicinal product to the blood stream.
Maltese: Minħabba li l-istratum corneum huwa l-pass li jillimita r-rata fl-għoti transdermali, kwalunkwe qasma tipprovdi aċċess dirett għall-epidermide, u dan potenzjalment iżid il-penetrazzjoni u jiffaċilita lmigrazzjoni tal-prodott mediċinali lejn il-fluss tad-demm.
English: In the subcutaneous fertility study in rats, while no effects were reported in males, in females, fertility was impaired and a NOAEL (no observed adverse effect level) of 5 mg/kg was identified.
Maltese: Fl-istudju subkutanju dwar il-fertilità fil-firien, waqt li l-ebda effett ma kien irrappurtat fil-firien maskili, fin-nisa, il-fertilità ġarrbet ħsara u kien identifikat NOAEL (livell li fih ma jkun osservat l-ebda effett avvers) ta' 5 mg/kg.
English: Emotional health subscale
Maltese: GĦAMLA KWALITATTIVA
English: Pliva Ljubljana d.o.o.
Maltese: - Ilwi l-garża lura fuqha nfisha.
English: Oxybutynin is extensively metabolised by the liver, see above, with less than 0.1% of the administered dose excreted unchanged in the urine.
Maltese: Oxybutynin huwa metabolizzat b'mod estensiv mill-fwied, ara fuq, b'inqas minn 0.1% tad-doża mogħtija titneħħa mhux mibdula fl-awrina.
English: Urinary retention, dysuria
Maltese: Subskala tar-relazzjonijiet soċjali
English: In patients with overactive bladder, characterised by detrusor muscle instability or hyperreflexia, cystometric studies have demonstrated that oxybutynin increases maximum urinary bladder capacity and increases the volume to first detrusor contraction.
Maltese: F'pazjenti bil-bużżieqa tal-awrina attiva ħafna, ikkaratterizzata minn instabbilità jew iperriflessija talmuskolu detrusor, studji ċistometriċi wrew li oxybutynin iżid il-kapaċità massima tal-bużżieqa tal-awrina u jżid il-volum għall-ewwel kontrazzjoni tad-detrusor.
English: Oxybutynin thus decreases urinary urgency and the frequency of both incontinence episodes and voluntary urination.
Maltese: B'dan il-mod oxybutynin inaqqas l-urġenza u lfrekwenza urinarja kemm ta' episodji ta' inkontinenza kif ukoll ta' għemil volontarju tal-awrina.
English: The concomitant use of oxybutynin with other anticholinergic medicinal products or with other agents that compete for CYP3A4 enzyme metabolism may increase the frequency or severity of dry mouth, constipation, and drowsiness.
Maltese: L-użu fl-istess ħin ta' oxybutynin ma' prodotti mediċinali antikolinerġiċi oħra jew ma' sustanzi oħra li jikkompetu għall-metaboliżmu tal-enzima CYP3A4 jista' jżid il-frekwenza jew is-severità ta' ħalq xott, stitikezza, u ħedla.
English: Urticaria, hot flushes
Maltese: Subskala tas-saħħa emozzjonali
English: The effect of showering on the absorption of oxybutynin was evaluated in a randomised, steady-state crossover study under conditions of no shower, or showering 1, 2 or 6 hours after Kentera application (N=20).
Maltese: L-effett tal-ħasil fid-doċċa fuq l-assorbiment ta' oxybutynin kien evalwat fi studju randomised, crossover fi stat fiss taħt kondizzjonijiet ta' ebda doċċa, jew ta' teħid ta'doċċa 1, 2 jew 6 sigħat wara l-applikazzjoni ta' Kentera (N=20).
English: You should discuss this problem with your doctor before using Kentera.
Maltese: Għandek tiddiskuti din il-problema mat-tabib tiegħek qabel tuża Kentera.
English: 2 transdermal patches 8 transdermal patches 24 transdermal patches
Maltese: .7 Effetti fuq il-ħila biex issuq u tħaddem magni
English: Name and address of the manufacturer(s) responsible for batch release
Maltese: A DETENTUR (I) TA' L-AWTORIZZAZZJONI TAL-MANIFATTURA RESPONSABBLI
English: Environmental Risk Assessment The active substance oxybutynin is persistent in the environment.
Maltese: Is-sustanza attiva oxybutynin hi persistenti fl-ambjent.
English: How to apply
Maltese: applikazzjoni.
English: Rebetol ribavirin
Maltese: Rebetol ribavirina
English: The full EPAR for Rebetol can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom need to be adjusted for patients who experience side effects.
Maltese: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom aġġustata għal pazjenti li jesperjenzaw effetti sekondarji.
English: It is available as capsules (200 mg) and as an oral solution (40 mg/ml).
Maltese: Jiġi bħala kapsuli (200 mg) u bħala soluzzjoni orali (40 mg/ml).
English: The active substance in Rebetol, ribavirin, is an antiviral belonging to the class ‘nucleoside analogues'.
Maltese: Is-sustanza attiva f'Rebetol, ir-ribavirina, hija antivirali li tappartjeni għall-klassi ‘analogi nukleosidiċi '.
English: In children weighing between 47 and 65 kg the dose ranges from 3 to 4 capsules.
Maltese: Fi tfal li jiżnu bejn 47 u 65 kg, id-doża tvarja minn 3 sa 4 kapsuli.
English: Other information about Rebetol
Maltese: Informazzjoni oħra dwar Rebetol
English: This is a summary of the European public assessment report (EPAR) for Rebetol.
Maltese: Dan id-dokument huwa sommarju tar-rapport pubblika Ewropew ta' valutazzjoni (EPAR) għal Rebetol.
English: Rebetol is a medicine that contains the active substance ribavirin.
Maltese: Rebetol huwa mediċina li fiha s-sustanza attiva ribavirina.
English: Rebetol has also been studied in 177 children and adolescents aged between three and 17 years who had not been treated before.
Maltese: Rebetol ġie studjat ukoll f'177 tifel u tifla u adoloxxenti ta' bejn tliet snin u 17-il sena li ma kinux ġew ikkurati qabel.
English: Rebetol has been studied in a total of over 6,000 adults who had not been treated before, including 328 patients with cirrhosis and 507 patients also infected with HIV.
Maltese: Rebetol ġie studjat f'total ta' aktar minn 6,000 adult li ma kinux ġew ikkurati qabel, inkluż 328 pazjent b'ċirrożi u 507 pazjenti li kienu infettati bl-HIV ukoll.
English: Additional data from the published literature show the positive effects of ribavirin-containing medicines when taken in different combinations, including combinations with peginterferon alfa-2a and a class of medicines known as direct acting antivirals (or DAAs).
Maltese: Data addizzjonali mid-dokumentazzjoni ppubblikata turi l-effetti pożittivi ta' mediċini li fihom irribavirina meta jittieħdu f'kombinazzjonijiet differenti, inkluż kombinazzjonijiet b'peginterferon alfa-2a u klassi ta' mediċini magħrufa bħala antivirali li jaġixxu b'mod dirett (jew DAAs).
English: Haemolytic anaemia (anaemia caused by abnormal breakdown of red blood cells) is a common side effect (seen in between 1 and 10 patients in 100), usually during the first few weeks of treatment.
Maltese: Anemija emolitika (anemija kkawżata minn tkissir anormali ta' ċelloli ħomor) hija effett sekondarju komuni (li deher bejn 1 u 10 pazjenti f'100), li s-soltu jidher matul l-ewwel ftit ġimgħat ta' kura.
English: Two main studies involving 1,503 adult patients with type 1 hepatitis C and compensated liver disease investigated the effect of ribavirin in a triple therapy combination with peginterferon alfa-2b and boceprevir.
Maltese: Żewġ studji ewlenin li jinvolvu 1,503 pazjent adult bl-epatite Ċ tat-tip 1 u mard tal-fwied ikkumpensat, investigaw l-effett ta' ribavirina f'taħlita ta' terapija trippla ma' peginterferon alfa-2b u boċeprevir.
English: In adults who had not been treated before, Rebetol in combination with interferon alfa 2b was more effective than interferon alfa 2b on its own, with 41% of the patients responding to the combination treatment and 16% to the interferon alone.
Maltese: F'adulti li ma kinux ġew ikkurati qabel, Rebetol f'kombinazzjoni ma' interferon alfa-2b kien aktar effettiv minn interferon alfa-2b użat waħdu, b'41% tal-pazjenti jwieġbu għall-kura ta' kombinazzjoni u 16% għal interferon waħdu.
English: Rebetol in combination with peginterferon alfa 2b was also effective in adults with cirrhosis or HIV.
Maltese: Rebetol f'kombinazzjoni ma' peginterferon alfa-2b kien effettiv wkoll f'adulti b'ċirrożi jew HIV.
English: Children above 3 years of age and adolescents who weigh less than 47 kg or who cannot swallow capsules should take the oral solution at a dose of 15 mg per kilogram body weight a day.
Maltese: Tfal minn 3 snin 'il fuq u adoloxxenti li jiżnu inqas minn 47 kg jew li ma jistgħux jibilgħu għandhom jieħdu s-soluzzjoni orali f'doża ta' 15 mg għal kull kilogramm tal-piż tal-ġisem kuljum.
English: How has Rebetol been studied?
Maltese: Kif ġie studjat Rebetol?
English: In all of the studies, Rebetol was given in combination with interferon alfa-2b or peginterferon alfa-2b.
Maltese: F'dawn l-istudji kollha, Rebetol ingħata f'kombinazzjoni ma' interferon alfa-2b jew peginterferon alfa-2b.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Rebetol on 7 May 1999.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq għal Rebetol valida fl-Unjoni Ewropea kollha fis-7 ta' Mejju 1999.
English: What is Rebetol?
Maltese: X'inhu Rebetol?
English: The Committee noted that Rebetol in combination with other medicines, including peginterferon alfa and DAAs is effective against long-term hepatitis C virus infection in adults and children.
Maltese: Il-Kumitat osserva li Rebetol f'kombinazzjoni ma' mediċini oħra, inkluż peginterferon alfa u DAAs huwa effettiv kontra l-infezzjoni fit-tul bil-virus tal-epatite Ċ fl-adulti u fit-tfal.
English: The CHMP decided that Rebetol's benefits are greater than its risks and recommended that it be given marketing authorisation.
Maltese: Is-CHMP iddeċieda li Rebetol għandu iktar benefiċċji milli riskji u rrakkomanda li jingħata awtorizzazzjoni għat-tqegħid fis-suq.
English: In the studies on triple therapy in patients with type 1 hepatitis C and compensated liver disease, ribavirin in combination with peginterferon alfa 2b and boceprevir was shown to be more effective than the dual combination with peginterferon alfa 2b alone.
Maltese: Fl-istudji dwar it-terapija trippla f'pazjenti bl-epatite Ċ tat-tip 1 u mard tal-fwied ikkumpensat, intwera li r-ribavirina flimkien ma' peginterferon alfa 2b u boċeprevir hija aktar effettiva mit-taħlita doppja ma' peginterferon alfa 2b waħedha.
English: Response rates were higher when Rebetol was used with peginterferon alfa 2b.
Maltese: Ir-rati ta' rispons kienu ogħla meta Rebetol intuża ma' peginterferon alfa2b.
English: A risk management plan has been developed to ensure that Rebetol is used as safely as possible.
Maltese: Ġie żviluppat pjan ta' ġestjoni tar-riskju biex jiġi żgurat li Rebetol jintuża bl-aktar mod sigur possibbli.
English: It has also been studied in 1,699 adults whose disease had come back after previous treatment or whose previous treatment had failed.
Maltese: Ġie studjat ukoll f'1,699 adult li l-marda tagħhom reġgħet tfaċċat wara kura preċedenti jew li l-kura preċedenti tagħhom ma kinitx irnexxiet.
English: Why has Rebetol been approved?
Maltese: Għaliex ġie approvat Rebetol?
English: Triple therapy led to a 30% increase in the number of previously untreated early responders who were cured after six months.
Maltese: It-terapija trippla wasslet għal żieda ta' 30% fin-numru ta' pazjenti li rrispondew kmieni li ma ġewx ikkurati qabel, li fiequ wara sitt xhur.
English: Recocam meloxicam
Maltese: Recocam meloxikam
English: This summary was last updated on: 02-2013.
Maltese: Dan is-sommarju ġie aġġornat l-aħħar fi: 02-2013.
English: Other information about Recocam:
Maltese: Aktar tagħrif dwar Recocam:
English: Recocam is a ‘generic' medicine which means that Recocam is similar to a ‘reference veterinary medicine' already authorised in the EU (Metacam).
Maltese: Recocam huwa mediċina ‘ġenerika' li jfisser li Recocam huwa simili għal ‘mediċina veterinarja ta' referenza' li hija diġà awtorizzata fl-UE (Metacam).
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Recocam on 13/09/2011.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida madwar l-Unjoni Ewropea għal Recocam fil-13/09/2011.
English: It is available as a clear yellow solution for injection (20 mg/ml).
Maltese: Din il-mediċina hija disponibbli f'soluzzjoni safra ċara għall-injezzjoni (20 mg/ml).
English: In cattle it is used together with appropriate antibiotics, to reduce clinical signs of acute respiratory infection (infection of the lungs and airways) and to treat acute mastitis (inflammation of the udder).
Maltese: Recocam jintuża fil-bhejjem tal-ifrat, flimkien antibijotiċi addattati, għat-tnaqqis ta' sintomi kliniċi f'infezzjoni respiratorja akuta (infjammazzjoni tal-pulmun u l-passaġġi tal-arja) u għat-trattament talmastite akuta (infjammazzjoni tal-glandola mammarja).
English: Why has Recocam been approved?
Maltese: Għaliex ġie approvat Recocam?
English: A second dose may be given after 24 hours if required.
Maltese: Jekk ikun hemm bżonn, tista' tingħata doża oħra wara 24 siegħa.
English: If you want more information on the basis of the CVMP recommendations, read the Scientific Discussion (also part of the EPAR).
Maltese: Jekk trid aktar informazzjoni abbażi tar-rakkomandazzjonijiet tas-CVMP, aqra dDiskussjoni Xjentifika (hija parti wkoll mill-EPAR).
English: Recocam is a medicine for cattle, pigs and horses that contains the active substance meloxicam.
Maltese: Recocam hija mediċina għall-bhejjem tal-ifrat, ħnieżer u żwiemel u fiha s-sustanza attiva meloxicam.
English: What is Recocam?
Maltese: Kif jaħdem Recocam?
English: In cattle and pigs, subcutaneous, intramuscular and intravenous administration is well tolerated; only a slight transient swelling at the injection site following subcutaneous administration was observed in less than 10% of cattle treated in clinical studies.
Maltese: L-għoti minn taħt il-ġilda u intramuskolari huwa tollerat sew fil-bhejjem tal-ifrat u fil-ħnieżer; ġiet osservata biss nefħa provviżorja fis-sit tal-injezzjoni wara l-għoti minn taħt il-ġilda f'inqas mill-10% tal-bhejjem tal-ifrat ittrattati fi studji kliniċi.
English: How has Recocam been studied?
Maltese: Kif ġie studjat Recocam?
English: It is used in pigs to reduce the symptoms of lameness and inflammation in non-infectious locomotor disorders (diseases that affect the ability to move) and for the treatment of certain diseases that occur after farrowing (giving birth) such as puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome), together with appropriate antibiotic therapy.
Maltese: Recocam jintuża fil-ħnieżer biex jitnaqqsu s-sintomi taz-zappip u l-infjammazzjoni f'disturbi mhux infettivi tal-mixi (mard li jaffettwa l-abbiltà tal-mixi) u għat-trattament ta' mard wara t-tifrigħ (il-ħlas) bħas-settiċemija u t-tossjemija tat-tifrigħ (is-sindromu tal-mastite-metrite-agalassija), flimkien ma'
English: It is given as a single injection of 0.4 mg per kg body weight into a muscle.
Maltese: Dan jingħata bħala injezzjoni singola ta' 0.4 mg għal kull kg tal-piż talġisem f'muskolu.
English: Recocam is given as a single injection of 0.6 mg per kg body weight into the horse's vein.
Maltese: Recocam jingħata bħala injezzjoni singola ta' 0.6 mg għal kull kg talpiż tal-ġisem f'muskolu.
English: The benefit-risk balance may be found in the scientific discussion module of this EPAR.
Maltese: Ilbilanċ benefiċċju-riskju jinsab fil-modulu tad-diskussjoni xjentifika ta' dan l-EPAR.
English: The CVMP considered that, in accordance with European Union requirements, Recoocam is bioequivalent to Metacam.
Maltese: Is-CVMP ikkonsidra li, skont ir-rekwiżiti tal-Unjoni Ewropea, Recocam huwa bijoekwivalenti għal Metacam.
English: How does Recocam work?
Maltese: X'inhu Recocam?
English: Recocam was considered to be bioequivalent with the reference medicine.
Maltese: Recocam ġie meqjus bħala bijoekwivalenti għall-mediċina ta' referenza.
English: What is the risk associated with Recocam?
Maltese: X'inhu r-riskju assoċjat ma' Recocam?
English: Although Recocam is a generic medicine no bioequivalence studies have been provided as the composition of the product is sufficiently similar to the reference product Metacam for the products to be considered essentially similar.
Maltese: Minkejja li Recocam huwa mediċina ġenerika, ma ssemmewx studji bijoekwivalenti minħabba li lkompożizzjoni tal-prodott hija simili biżżejjed għall-prodott ta' referenza Metacam rigward il-prodotti li jridu jiġu kkonsidrati similarment essenzjali.
English: Meloxicam acts by blocking an enzyme called cyclo-oxygenase which is involved in the production of prostaglandins.
Maltese: Recocam fih meloxicam, li jappartjeni għall-klassi ta' mediċini msejħa mediċini anti-infjammatorji mhux sterojdi (NSAIDs). Meloxicam jaġixxi billi jimblokka enzima msejħa ċiklo-ossiġenażi li hija involuta fil-produzzjoni tal-prostaglandina.
English: As the prostaglandins trigger inflammation, pain, exudation and fever, meloxicam reduces these clinical signs.
Maltese: Peress li l-prostaglandini joħolqu l-infjamazzjoni, l-uġigħ, ilħruġ ta' għaraq u d-deni, meloxicam inaqqas dawn ir-reazzjonijiet.
English: Recocam is used in horses to relieve colic (abdominal pain) and for the alleviation of inflammation and relief of pain in musculo-skeletal disorders.
Maltese: Fiż-żwiemel Recocam jintuża biex itaffi l-uġigħ koliku (uġigħ addominali) u l-infjamazzjoni kif ukoll luġigħ f'disturbi muskoskeletali.
English: Recocam is given in cattle as a single injection of 0.5 mg per kg body weight under the skin or into a vein.
Maltese: Recocam fl-ifrat jingħata bħala injezzjoni singola ta' 0.5 mg għal kull kg tal-piż tal-ġisem taħt il-ġilda jew f'vina.
English: People who are hypersensitive (allergic) to NSAIDs should avoid contact with Recocam.
Maltese: Il-persuni ipersensittivi (allerġiċi) għall-NSAIDs għandhom jevitaw il-kuntatt ma' Recocam.
English: Consequently, Recocam's benefit is taken as being the same as that of the reference medicine.
Maltese: Għaldaqstant, il-benefiċċju ta' Recocam jitqies li huwa l-istess bħal dak tal-mediċina ta' referenza.
English: 88 days
Maltese: 88 ġurnata
English: Intramuscular injection (cattle, pigs).
Maltese: Injezzjoni intramuskolari (frat, majjali).
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION <{DD/MM/YYYY}> <{DD month YYYY}>
Maltese: <{DD/MM/YYYY}><{DD/month/YYYY}>
English: ROUTE(S) OF ADMINISTRATION Intramuscular injection
Maltese: MOD(I) TA' AMMINISTRAZZJONI Injezzjoni intramuskolari
English: Escherichia coli resistance has been reported.
Maltese: Reżistenza għal Escherichia coli resistance ġiet irrapurtata.
English: The dosage was repeated 48 hours later.
Maltese: Id-doża ġiet ripetuta wara 48 siegħa.
English: 4.6 Adverse reactions (frequency and seriousness)
Maltese: 4..6 Effetti mhux mixtieqa (frekwenza u gravità)
English: Marker residue
Maltese: Residwu talMarkatur
English: Amoxicillin belongs to β-lactams antibiotic family.
Maltese: Amoksiċillina jappartieni lill-familja antibijotika tat-tip β-lactam.
English: 2.5 days
Maltese: 2.5 jiem
English: Benzyl alcohol
Maltese: Alkoħol benżil
English: Amoxicillin is active against susceptible Gram positive and Gram negative bacteria.
Maltese: Amoksiċillina hu attiv kontra batterji suxxettibbli Gram pożittiv u Gram negattiv.